DEBUG: PAGE=article, TITLE=Our Team,ID=1464,TEMPLATE=analyst

Alisa Samoylova

Alisa is a Market Analyst with responsibility for Procurement BPS and Healthcare BPS research.

Wipro - Pharmaceuticals / Life Sciences Operational Transformation

Vendor Analysis

by Alisa Samoylova

published on Jan 21, 2022

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

This NelsonHall vendor assessment analyzes Wipro's offerings and capabilities in Pharmaceuticals / Life Sciences Operational Transformation

Who is this Report for:

NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Wipro is a comprehensive assessment of Wipros offerings and capabilities, designed for:

  • Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
  • Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
  • Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.

Scope of this Report:

The report provides a comprehensive and objective analysis of Wipro’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:

  • Identification of the company’s strategy, emphasis, and new developments
  • Analysis of the company’s strengths, weaknesses, and outlook
  • Revenue estimates
  • Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
  • Analysis of the company’s offerings and key service components
  • Analysis of the company’s delivery organization, including the location of delivery locations.

Key Findings & Highlights:

Wipro focuses on the entire healthcare and life sciences ecosystem comprised of patients, physicians, payors, pharmaceutical companies, providers, pharmacists, and regulatory agencies. Wipro's offerings cover the end-to-end pharmaceuticals/life sciences value chain. Wipro brings both the partner ecosystem, in-house tools, and Wipro IPs in any engagement.

Typically Wipro works with the client in the following way:

  • Identifies business problems together with the client
  • Prioritizes and selects the problems to address
  • Forms agile teams together with client resources
  • Composes the acceleration cell by innovation orchestration
  • Makes innovation sprints for solution creation together with start-up partners
  • Graduates successful experiments to innovation projects and gives feedback from any futile experiments.

Login to get full access:

close